OBIO TECHNOLOGY (SHANGHAI) CORP LTD revenue breakdown overview

OBIO TECHNOLOGY (SHANGHAI) CORP LTD revenue for the last year amounted to 248.00 M CNY, the most of which — 134.94 M CNY — came from its highest performing source at the moment, Cell and Gene Therapy Contract Development and Manufacturing Organization, the year earlier bringing 106.99 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought OBIO TECHNOLOGY (SHANGHAI) CORP LTD 243.40 M CNY, and the year before that — 204.49 M CNY.